Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week
Yahoo Finance · 2 weeks ago
Open | 56.79 |
High | 57.30 |
Low | 56.41 |
Mkt Cap | 12.8B |
P/E (TTM) | 17.25 |
Div & Yield | N/A & N/A |
Prev. Close | 57.25 |
52 Wk. Low | 50.27 |
52 Wk. High | 67.36 |
Related stocks
American pharmaceutical company
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 880.89M | 8.90% ▲ |
Net Income | 169.55M | 681.20% ▲ |
Diluted EPS | 0.64 | 670.50% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.09 | - |
Q1 2024 | $0.84 | $0.64 |
Q4 2023 | $1.16 | $1.06 |
S&P FuturesES=F | 5,252.25-31.75 (-0.60%) |
Dow FuturesYM=F | 38,180.00-344.00 (-0.89%) |
Nasdaq FuturesNQ=F | 18,667.50-135.25 (-0.72%) |
271.62+0.66% | |
UiPath Inc.PATH | 18.30-2.40% |
23.92-0.75% |